Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RN1002 for acceleration of early wound healing in punch biopsy wounds
2004-001458-10Phase 2Completed
- Sponsor
- Renovo
- Start
- Feb 2005
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of estradiol in Abnormal wound healing (6 arms), sponsored by Renovo. Primary endpoint: Early epithelialization distance over biopsy site. Started Feb 2005; status: completed.
02
Drugs
estradiol
03
Conditions
Abnormal wound healing
Beyond the preview
Go deeper on 2004-001458-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001458-10.